Trial Profile
An Open Label Study in Healthy Volunteers to Evaluate the Potential for Drug/Drug Interactions Between F901318 and Fluconazole
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Mar 2021
Price :
$35
*
At a glance
- Drugs Olorofim (Primary) ; Fluconazole
- Indications Coccidioidomycosis; Invasive bronchopulmonary aspergillosis; Mycoses
- Focus Adverse reactions
- Sponsors F2G
- 01 Feb 2017 Status changed from recruiting to completed.
- 08 Jun 2016 Status changed from not yet recruiting to recruiting.
- 13 Apr 2016 New trial record